GPN vs RLMD · P/E 24, rev $6.29B vs $692.3M cap
Global Payments Inc (GPN) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
RLMD does not have a complete income-statement cache yet.
GPN currently screens at market cap $18.14B and trailing P/E 24.4. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the GPN and RLMD stock pages for the full models.
Not investment advice.